Liquid Formulation Capsules Manufacturer
Innoval Pharma is a premier contract development and manufacturing organization (CDMO) specializing in liquid-filled hard-shell capsule (LFC) solutions for pharmaceutical and biotech partners worldwide. With decades of formulation expertise and state-of-the-art cGMP manufacturing capabilities, we help sponsors overcome complex drug delivery challenges—from early-phase development through commercial scale-up.
Our FDA-inspected facility features Grade C/D cleanrooms, dedicated potent compound handling areas, and integrated analytical laboratories to ensure batch consistency and regulatory compliance at every stage. Whether your active pharmaceutical ingredient (API) suffers from poor solubility, low bioavailability, or high potency, our LFC technology offers a proven, scalable pathway to accelerate your product’s journey from concept to clinic. We combine scientific rigor with operational agility, delivering up to 40% time savings through our integrated formulation, manufacturing, and analytical services.
Liquid Formulation Capsules Manufacturer
Product Display
No products found
Benefits
Enhanced Bioavailability for Poorly Soluble APIs
Enhanced Bioavailability for Poorly Soluble APIs
Liquid-filled capsules are an optimal delivery system for APIs with poor water solubility and low bioavailability. By dissolving or suspending the active ingredient in lipophilic vehicles, co-solvents, and surfubilizing agents, we create formulations that achieve faster absorption and higher plasma concentrations compared to traditional solid dosage forms. This approach has demonstrated dramatic improvements in pharmacokinetic performance, with some formulations outperforming commercial reference products by multiple fold in Cmax and AUC.
Superior Content Uniformity for Low-Dose & Potent Compounds
Superior Content Uniformity for Low-Dose & Potent Compounds
For high-potency or low-dose APIs, achieving precise content uniformity is critical. Liquid-filled capsules distribute the active ingredient evenly throughout the liquid or semi-solid matrix, eliminating the blending variability and segregation risks common with powder-filled formulations. This ensures consistent dosing from capsule to capsule and batch to batch—a vital advantage for compounds with narrow therapeutic indices and stringent regulatory requirements.
Exceptional Product Stability & Shelf Life
Exceptional Product Stability & Shelf Life
Hard-shell capsules provide lower moisture content and reduced gas transmission compared to softgels, creating a more protective environment for sensitive APIs. When combined with our advanced band-sealing technology, LFCs deliver outstanding physical and chemical stability across varying storage conditions. This enhanced stability profile minimizes degradation, extends shelf life, and reduces the need for complex packaging interventions, ultimately lowering total cost of ownership.
Seamless Scalability from Clinical to Commercial
Seamless Scalability from Clinical to Commercial
Our LFC manufacturing process is inherently simple and efficient, requiring fewer excipients and enabling rapid scale-up from hand-filled prototype batches to high-volume commercial production. With advanced encapsulation equipment, validated processes, and 100% manual inspection, we ensure consistent quality at every batch size. This scalability reduces development risk, accelerates timeline transitions between clinical phases, and supports long-term commercial supply security.
Enhanced Bioavailability for Poorly Soluble APIs
Enhanced Bioavailability for Poorly Soluble APIs
Liquid-filled capsules are an optimal delivery system for APIs with poor water solubility and low bioavailability. By dissolving or suspending the active ingredient in lipophilic vehicles, co-solvents, and surfubilizing agents, we create formulations that achieve faster absorption and higher plasma concentrations compared to traditional solid dosage forms. This approach has demonstrated dramatic improvements in pharmacokinetic performance, with some formulations outperforming commercial reference products by multiple fold in Cmax and AUC.
Superior Content Uniformity for Low-Dose & Potent Compounds
Superior Content Uniformity for Low-Dose & Potent Compounds
For high-potency or low-dose APIs, achieving precise content uniformity is critical. Liquid-filled capsules distribute the active ingredient evenly throughout the liquid or semi-solid matrix, eliminating the blending variability and segregation risks common with powder-filled formulations. This ensures consistent dosing from capsule to capsule and batch to batch—a vital advantage for compounds with narrow therapeutic indices and stringent regulatory requirements.
Exceptional Product Stability & Shelf Life
Exceptional Product Stability & Shelf Life
Hard-shell capsules provide lower moisture content and reduced gas transmission compared to softgels, creating a more protective environment for sensitive APIs. When combined with our advanced band-sealing technology, LFCs deliver outstanding physical and chemical stability across varying storage conditions. This enhanced stability profile minimizes degradation, extends shelf life, and reduces the need for complex packaging interventions, ultimately lowering total cost of ownership.
Seamless Scalability from Clinical to Commercial
Seamless Scalability from Clinical to Commercial
Our LFC manufacturing process is inherently simple and efficient, requiring fewer excipients and enabling rapid scale-up from hand-filled prototype batches to high-volume commercial production. With advanced encapsulation equipment, validated processes, and 100% manual inspection, we ensure consistent quality at every batch size. This scalability reduces development risk, accelerates timeline transitions between clinical phases, and supports long-term commercial supply security.
FAQ
What are liquid-filled hard-shell capsules, and how do they differ from softgels?
Liquid-filled hard-shell capsules (LFCs) consist of a two-piece hard capsule shell—available in gelatin or vegetarian options such as HPMC, potato starch, or carrageenan—filled with liquid, semi-solid, or suspension formulations. Unlike softgels, which use a single-piece gelatin shell, LFCs offer superior stability, lower moisture and gas permeability, and the unique ability to combine liquids with solid components like beads or pellets in one dosage form. The hard-shell matrix also provides greater mechanical robustness and broader excipient compatibility.
Which types of APIs are best suited for liquid-filled capsule formulation?
LFCs are ideal for APIs with poor water solubility and bioavailability, low melting points, high potency requiring precise dosing, and compounds needing enhanced stability protection. They are also well-suited for hot-fill liquids and formulations requiring sustained-release profiles. Our technical team evaluates each API’s physicochemical properties— including solubility, permeability, and thermal sensitivity—to determine whether LFC technology is the optimal delivery strategy for your specific molecule.
What capsule shell options does Innoval Pharma offer for liquid-filled products?
We provide both gelatin-based and vegetarian hard-shell options for liquid-filled capsules. Gelatin shells, sourced from collagen with a bloom strength of 220–280, offer proven performance and broad regulatory acceptance. For plant-based requirements, we offer HPMC (hydroxypropyl methylcellulose), potato starch, and carrageenan shells that meet vegan, kosher, and halal standards. HPMC capsules additionally support the use of higher-melting-point excipients, expanding formulation flexibility for challenging compounds.
How does Innoval Pharma ensure the quality and integrity of liquid-filled capsules during manufacturing?
Every LFC project follows a rigorous process validation protocol conducted prior to manufacture, identifying and resolving potential issues before they impact product quality. Our cGMP facility features ISO 7/8 and Grade C cleanrooms, environmental monitoring systems, and DEA-licensed capabilities for controlled substances. We perform 100% manual visual inspection of finished capsules, comprehensive in-process testing, and finished product release testing—including dissolution, disintegration, assay, and degradation analysis—to ensure every batch meets specifications before release.
Can Innoval Pharma support the entire drug development lifecycle, from formulation to commercial supply?
Absolutely. Innoval Pharma provides fully integrated CDMO services spanning preclinical formulation development, Phase I–IV clinical supply manufacturing, scale-up and engineering batches, validation batches, and commercial production. Our on-site R&D formulation labs, analytical method development and validation teams, ICH stability chambers, and clinical packaging capabilities operate from a single campus, enabling rapid turnaround and seamless technology transfers. This integrated approach eliminates vendor coordination delays and can reduce overall development timelines by up to 40%.
Unlock Your Medicine Production Potential. Speak with an Innoval Pharma Expert to Tailor Your Solution.
Certificates
Related Products
No products found
